HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pharmacokinetics and clinical efficacy of moxalactam in biliary tract infections.

Abstract
Moxalactam exhibited excellent in vitro activity against all pathogens commonly associated with biliary tract infections. The drug retained bactericidal activity against all of these organisms, with the possible exception of Klebsiella pneumoniae, even in the presence of bile. Pharmacokinetic studies revealed high concentrations of moxalactam in the bile after intravenous administration. Twenty-seven of 28 patients with severe, complicated biliary tract infections responded favorably to the administration of moxalactam.
AuthorsO Mueller, K Fabricius, E Krueger, U Rueckert
JournalReviews of infectious diseases (Rev Infect Dis) 1982 Nov-Dec Vol. 4 Suppl Pg. S688-91 ISSN: 0162-0886 [Print] United States
PMID6218584 (Publication Type: Journal Article)
Chemical References
  • Cephalosporins
  • Cephamycins
  • Moxalactam
Topics
  • Adult
  • Aged
  • Bacterial Infections (drug therapy, microbiology)
  • Biliary Tract Diseases (drug therapy)
  • Cephalosporins (therapeutic use)
  • Cephamycins (adverse effects, metabolism, therapeutic use)
  • Female
  • Humans
  • Kinetics
  • Male
  • Microbial Sensitivity Tests
  • Middle Aged
  • Moxalactam
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: